Oral Contraceptives Offer Some Protection Against Bone Loss in Anorexia Nervosa
For young women with anorexia nervosa, oral contraceptives may limit bone loss.
Contraception
New Title X Rule Threatens Contraceptive Access for American Women
A new rule by the Trump administration may make it more challenging for women to access contraceptive services, despite evidence of the benefits to women, families, and the nation as a whole.
Novel Androgen May Be a Potential Candidate for Male Hormonal Contraceptive
11β-MNTDC is a modified testosterone with androgenic and progestational activity that is being developed as a potential male contraceptive.
Genetic Variant May Put Some Women at Increased Risk for Contraception Failure
A genetic variant may play a major role in why hormonal contraception fails in some women, according to a new study published in Obstetrics & Gynecology.
Oral Contraceptive Product Recalled Due to Packaging Error
Apotex announced a voluntary recall of 4 lots of Drospirenone and Ethinyl Estradiol Tablets 3mg/0.03mg due to the possibility of defective blisters with incorrect tablet arrangements and/or empty blister pockets.
Endocrine Society Objects Changes to Title X Family Planning Program
The Endocrine Society has objected the US Department of Health & Human Services’ update to the Title X Family Planning Program.
Examining the Rush for Contraceptives After the 2016 Election
Researchers compared long-acting reversible contraceptive insertion rates in the 30 days before and after the 2016 presidential election.
Novel Combined Oral Contraceptive Effective in Phase 3 Trial
Previous Phase 2 studies confirmed esterol has minimal impact on liver cells and metabolic pathways, as well as on coagulation parameters.
FDA Announces Safety Monitoring Measures for Permanent Birth Control Essure
The U.S. Food and Drug Administration is implementing a number of steps for long-term safety monitoring of the permanent birth control device Essure, which will no longer be sold or distributed in the United States after Dec. 31, 2018.
Approximately 65% of Women in the United States Are Using Contraceptives
Almost two-thirds of U.S. women aged 15 to 49 years were currently using contraception in 2015 to 2017.
Next post in Androgen and Reproductive Disorders
